Matt is an Assistant Professor in the Department of Biostatistics at the University of Florida. His primary focus is evaluating the effectiveness of interventions against infectious disease, through clinical trials, observational studies, and development and application of mathematical models.
To this end, he is interested in trial design for infectious diseases, and in quantifying the role of different components of the immune response in providing protection against infection and disease. In collaboration with researchers from Brazil, he has conducted observational studies of COVID-19 vaccine effectiveness, and together with researchers from the US CDC Dengue Branch, he has worked on using serosurveys to understand transmission dynamics of dengue in the Caribbean.
96.4% of Americans had COVID-19 antibodies in their blood by fall 2022
Jun 16, 2023 06:03 am UTC| Health
CC BY-ND Antibodies to SARS-CoV-2, the virus that causes COVID-19, were present in the blood of 96.4% of Americans over the age of 16 by September 2022. Thats according to a serosurvey an analysis testing for the...